Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt
Radwa Mehanna
Affiliation Alexandria University
Country Egypt
Scopus ID 55851530300
Documents 43
Citations 927
h-index 19
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

References

  1. Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
    https://esev-eg.org/board/
  2. Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
    https://doi.org/10.4252/wjsc.v14.i1.1
  3. Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
    https://doi.org/10.1186/s40659-025-00593-7
  4. Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
    https://doi.org/10.1093/eurheartj/suab069.019
  5. Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
    https://doi.org/10.1016/j.vph.2023.107223

Ersilia Nigro | Cardiovascular Researches | Innovative Research Award

Innovative Research Award

Ersilia Nigro
Università della Campania Vanvitelli, Italy

Ersilia Nigro
Affiliation Università della Campania Vanvitelli
Country Italy
Scopus ID 57194323816
Documents 119
Citations 3,964
h-index 33
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-5637-1685

The Innovative Research Award recognizes the scholarly contributions of Ersilia Nigro, an Italian researcher affiliated with Università della Campania Vanvitelli, whose work has advanced knowledge in cardiovascular and metabolic sciences. Her interdisciplinary research explores adipokines, inflammatory biomarkers, exercise physiology, metabolic dysfunction, and lifestyle-related determinants of cardiovascular health. With an established publication record, a Scopus h-index of 33, and nearly four thousand citations, her investigations have contributed to translational approaches linking molecular mechanisms with clinical practice.[1]

Abstract

This article summarizes the scientific profile of Ersilia Nigro in relation to the Innovative Research Award. Her work integrates molecular cardiology, metabolism, and preventive medicine, emphasizing biomarkers associated with obesity, inflammation, exercise adaptation, and cardiovascular risk. Current research demonstrates sustained engagement with emerging topics including adiponectin signaling, orexin regulation, muscle wasting, and cardiometabolic interventions.[2]

Keywords

Cardiovascular research; adipokines; exercise physiology; obesity; inflammation; cardiometabolic health; translational medicine; biomarkers.

Introduction

Contemporary cardiovascular science increasingly relies on multidisciplinary investigations connecting lifestyle behaviors with molecular pathways. Nigro’s research addresses this need by examining how exercise, nutrition, sleep, and metabolic dysfunction influence cardiovascular outcomes and chronic disease progression.[3]

Research Profile

Her publication portfolio spans clinical, translational, and experimental studies. Indexed in Scopus with 119 documents and 3,964 citations, her scholarship demonstrates sustained influence across cardiovascular medicine, endocrinology, and metabolic research. Collaborative investigations frequently examine biomarker-driven approaches to patient stratification and disease management.[1]

Research Contributions

  • Investigation of adiponectin isoforms and inflammatory biomarkers in chronic diseases.
  • Evaluation of exercise interventions and their effects on cardiometabolic health.
  • Analysis of lifestyle factors, including sleep and nutrition, in cardiovascular regulation.
  • Research on muscle wasting, dyslipidemia, and patient management strategies in chronic respiratory disorders.

Publications

Recent publications include studies on irisin responses in obese middle-aged males, exercise-induced modulation of adiponectin, orexin and lifestyle habits, COPD-associated muscle wasting, and inflammatory markers in Crohn’s disease.[4]

Research Impact

The impact of Nigro’s work is reflected in extensive citation activity and the adoption of biomarker-based approaches within cardiometabolic research. Her studies support evidence-informed strategies for prevention, risk assessment, and personalized interventions targeting obesity-related cardiovascular conditions.[5]

Award Suitability

The Innovative Research Award acknowledges scientific originality, interdisciplinary collaboration, and measurable influence. Nigro’s sustained contributions across cardiovascular medicine, molecular biology, and preventive health align with these criteria through a record of peer-reviewed outputs, translational relevance, and international visibility.[6]

Conclusion

Ersilia Nigro has established a significant research profile at the intersection of cardiovascular science and metabolism. Her investigations continue to inform understanding of biomolecular pathways underlying cardiometabolic disorders while advancing preventive and therapeutic perspectives relevant to contemporary healthcare challenges.

References

  1. Elsevier. (n.d.). Scopus author details: Ersilia Nigro, Author ID 57194323816. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57194323816
  2. Nigro, E., et al. (2026). Effects of Two Different Training Programs on Cardiometabolic Health, Body Composition and Irisin in Middle Age Obese Males: A Pilot Study. Life.
    DOI: https://doi.org/10.3390/life16040657
  3. Nigro, E., et al. (2025). Orexin and Lifestyle Habits: A Meaningful Connection Among Nutrition, Physical Activity, and Sleep Pattern in Health and Diseases. International Journal of Molecular Sciences.
    DOI: https://doi.org/10.3390/ijms26188980
  4. Nigro, E., et al. (2026). Acute Resistance Exercise Temporarily Reduces Circulating Adiponectin in Trained Young Men: A Pilot Study. Biomolecules. DOI: https://doi.org/10.3390/biom16020229
  5. Nigro, E., et al. (2025). Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13081817
  6. Nigro, E., et al. (2025). Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn’s Disease Patients. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13020273

Fengxu Yu | Atrial Fibrillation | Best Researcher Award 

Fengxu Yu | Atrial Fibrillation | Best Researcher Award 

The Affiliated Hospital of Southwest Medical University | China

Author Profile:

Scopus

👨‍⚕️ MR. FENGXU YU – PIONEER IN CARDIOVASCULAR INNOVATION

🎓 EARLY ACADEMIC PURSUITS

Born in January 1976, Professor Fengxu Yu embarked on his medical journey with a strong academic foundation, earning his M.D. and later achieving qualifications as a doctoral supervisor. His passion for cardiovascular science led him to pursue postdoctoral training in France, equipping him with a global perspective and refined clinical research skills. This international exposure laid the groundwork for his future leadership in complex cardiovascular research and surgical practice.

💼 PROFESSIONAL ENDEAVORS

Currently serving as a Professor at The Affiliated Hospital of Southwest Medical University, Dr. Yu holds several distinguished roles:

  • Standing Committee Member, Cardiac Surgery Committee (CAMEA)

  • Committee Member, Heart Valve Committee (CRHA)

  • Vice Chair, Sichuan Thoracic & Cardiac Surgery Association

  • Academic Leader, recognized by the Sichuan Health Commission

  • Member, Asian Heart Valve Society, China Chapter

  • Recipient, Luzhou Top Talent Award

His consistent dedication has cemented his role as a leading figure in thoracic and cardiac surgery across China.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ATRIAL FIBRILLATION

Dr. Yu’s research endeavors focus on molecular and biomechanical mechanisms in cardiovascular disease, especially atrial fibrillation (AF), atherosclerosis, and aortic dissection. His current areas of exploration include:

  • Non-coding RNAs (e.g., circRNA/ceRNA networks) in AF pathogenesis

  • Application of induced pluripotent stem cells in modeling AF

  • Effects of shear stress on vascular endothelial health and its link to atherosclerosis

Through these efforts, Dr. Yu bridges basic science with clinical relevance, advancing the future of personalized medicine.

📊 IMPACT AND INFLUENCE

As a principal investigator, Dr. Yu has led nearly 20 major research projects funded by provincial and municipal institutions. He has also contributed to 30+ collaborative studies as a lead or co-investigator. His academic output includes over 50 peer-reviewed publications, with 12 articles indexed in SCI journals and 20+ papers in national core journals, showcasing his thought leadership in cardiovascular science.

📚 SELECTED RESEARCH PROJECTS

Some of Dr. Yu’s notable funded projects include:

  • Mechanism of Shear Stress-Downregulated Annexin A1 (2019)

  • circRNA-Regulated ceRNA Networks in AF (2025)

  • Personalized Warfarin Therapy Post-Valve Replacement (2022)

  • Hsa_circ_0025573—miR-133b—MMP9 in AF Pathogenesis (2022)

  • SRB1-Mediated Endothelial Injury in Atherosclerosis (2018)

These projects reflect a multidisciplinary approach to understanding and treating cardiovascular conditions.

🏅 ACADEMIC CITES AND MEMBERSHIPS

Professor Yu actively contributes to national and international academic bodies. His memberships include:

  • CAMEA – Cardiac Surgery Committee

  • CRHA – Heart Valve Committee

  • Sichuan Thoracic & Cardiac Surgery Association

  • Asian Heart Valve Society – China Chapter

These affiliations enhance his visibility in shaping future cardiac surgery standards and innovations.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Professor Fengxu Yu is a mentor, innovator, and academic leader. His mentorship of graduate students, collaboration with international institutions such as Heidelberg University, and continued work on translational research ensure a legacy of impactful science. As cardiovascular disease remains a global challenge, his pioneering work in non-coding RNA and biomechanical interactions is poised to redefine prevention and treatment strategies.

📑 NOTABLE PUBLICATIONS

"Myocardial infarction serum preconditioning bone marrow mesenchymal stem cell-derived exosomes enhance anti-fibrosis in rat myocardial infarction hearts" 

Authors: Y., Gan, Yang , C., Wang, Changyi , R., Liao, Ruili , ... H., Liu, Hui , Y., Fu, Yong
Journal: Molecular and Cellular Biochemistry.
Year: 2025

"Identification of the optimal reference genes for atrial fibrillation model established by iPSC-derived atrial myocytes" 

Authors: L., Li, Lei , Z., Zhao, Zijuan , Z., Liu, Zihao , ... Y., Nie, Yongmei , F., Yu, Fengxu
Journal: BMC Genomics
Year: 2024

"Postoperative delirium prediction after cardiac surgery using machine learning models" 

Authors: T., Yang, Tan , H., Yang, Hai , Y., Liu, Yan , ... Y., Zhang, Ying , F., Yu, Fengxu
Journal: Computers in Biology and Medicine
Year: 2024